Product Reports Resources Pricing Login Book a demo

Altos Labs

Biotech & Life Sciences · Los Altos, United States · Founded 2021

Biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming

Investors

4 investors on Altos Labs's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Global footprint

Where Altos Labs has talent and traffic

Workforce by country
11 countries with
team presence
🇺🇸 United States72.8%
🇬🇧 United Kingdom24.3%
🇪🇸 Spain0.8%
🇵🇹 Portugal0.7%
🇨🇦 Canada0.3%
Top 5 of 11 shown
Web traffic by country
51K monthly visits
across markets
🇺🇸 United States30.8%
🇩🇪 Germany10.6%
🇨🇦 Canada10%
🇬🇧 United Kingdom9.2%
🏳️ Korea7.3%
Top 5 markets shown

Talent graph

The shape of Altos Labs's talent

Dealroom maps Altos Labs's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

29 standout operatorsDealroom-flagged across the org
24 AI specialistsincl. 20 core researchers
559 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Altos Labs's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$6M patent portfolio · 13 active families

Estimated portfolio value
$6M
0.04% of valuation · 37.4× smaller than top peer Zealand Pharma ($240M)
13 active patent families
Where Altos Labs innovates ATF6BiochemistryBiomedical engineeringBiophysicsCell

Where Altos Labs concentrates vs peers

Each axis is a top-10 topic across Altos Labs and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Altos Labs's 1 investments and acquisitions.

Every disclosed deal where Altos Labs appeared as a backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

1 deals across Altos Labs's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Altos Labs's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        1 of 1 deals

        Market sentiment

        What the market is saying about Altos Labs

        An AI-synthesized read of the highest-engagement posts about Altos Labs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Altos Labs on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.